Literature DB >> 23933204

Sex and estrogen receptor expression influence opioid peptide levels in the mouse hippocampal mossy fiber pathway.

Tracey A Van Kempen1, Sana Kahlid, Andreina D Gonzalez, Joanna L Spencer-Segal, Mumeko C Tsuda, Sonoko Ogawa, Bruce S McEwen, Elizabeth M Waters, Teresa A Milner.   

Abstract

The opioid peptides, dynorphin (DYN) and enkephalin (L-ENK) are contained in the hippocampal mossy fiber pathway where they modulate synaptic plasticity. In rats, the levels of DYN and L-ENK immunoreactivity (-ir) are increased when estrogen levels are elevated (Torres-Reveron et al., 2008, 2009). Here, we used quantitative immunocytochemistry to examine whether opioid levels are similarly regulated in wildtype (WT) mice over the estrous cycle, and how these compared to males. Moreover, using estrogen receptor (ER) alpha and beta knock-out mice (AERKO and BERKO, respectively), the present study examined the role of ERs in rapid, membrane-initiated (6 h), or slower, nucleus-initiated (48 h) estradiol effects on mossy fiber opioid levels. Unlike rats, the levels of DYN and L-ENK-ir did not change over the estrous cycle. However, compared to males, females had higher levels of DYN-ir in CA3a and L-ENK-ir in CA3b. In WT and BERKO ovariectomized (OVX) mice, neither DYN- nor L-ENK-ir changed following 6 or 48 h estradiol benzoate (EB) administration. However, DYN-ir significantly increased 48 h after EB in the dentate gyrus (DG) and CA3b of AERKO mice only. These findings suggest that cyclic hormone levels regulate neither DYN nor L-ENK levels in the mouse mossy fiber pathway as they do in the rat. This may be due to species-specific differences in the mossy fiber pathway. However, in the mouse, DYN levels are regulated by exogenous EB in the absence of ERα possibly via an ERβ-mediated pathway requiring new gene transcription.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  AERKO; BDNF; BERKO; BSA; CA1; CA3; CA3 region; DG; DYN; Dentate gyrus; EB; ER; G-protein-coupled estrogen receptor 1; GPER1; Hil; IgG; L-ENK; LTP; OVX; Opioids; PB; Synaptic plasticity; TS; WT; bovine serum albumin; brain derived neurotrophic factor; cornu ammonis 1 region; cornu ammonis 3 region; dentate gyrus; dynorphin; estradiol benzoate; estrogen receptor; estrogen receptor alpha knock out mice; estrogen receptor beta knock out mice; glc; granule cell layer; hilus of the dentate gyrus; immunoglobulin; immunoreactivity; ir; leu-enkephalin; long term potentiation; ovariectomy; pcl; phosphate buffer; pyramidal cell layer; slu; sr; stratum lucidum; stratum radiatum; tris–saline; wild-type mice

Mesh:

Substances:

Year:  2013        PMID: 23933204      PMCID: PMC3857632          DOI: 10.1016/j.neulet.2013.07.048

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  37 in total

Review 1.  Molecular basis of long-term plasticity underlying addiction.

Authors:  E J Nestler
Journal:  Nat Rev Neurosci       Date:  2001-02       Impact factor: 34.870

Review 2.  Stress and hippocampal plasticity.

Authors:  B S McEwen
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

Review 3.  Sex and estrogen influence drug abuse.

Authors:  Marilyn E Carroll; Wendy J Lynch; Megan E Roth; Andrew D Morgan; Kelly P Cosgrove
Journal:  Trends Pharmacol Sci       Date:  2004-05       Impact factor: 14.819

4.  Impaired short-term plasticity in mossy fiber synapses caused by mitochondrial dysfunction of dentate granule cells is the earliest synaptic deficit in a mouse model of Alzheimer's disease.

Authors:  Sang Hun Lee; Kyung-Ran Kim; Shin-Young Ryu; Sungmin Son; Hyun Seok Hong; Inhee Mook-Jung; Suk-Ho Lee; Won-Kyung Ho
Journal:  J Neurosci       Date:  2012-04-25       Impact factor: 6.167

5.  The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation.

Authors:  M G Weisskopf; R A Zalutsky; R A Nicoll
Journal:  Nature       Date:  1993-04-01       Impact factor: 49.962

6.  Dentate gyrus and hilus transection blocks seizure propagation and granule cell dispersion in a mouse model for mesial temporal lobe epilepsy.

Authors:  Johan Pallud; Ute Häussler; Mélanie Langlois; Sophie Hamelin; Bertrand Devaux; Colin Deransart; Antoine Depaulis
Journal:  Hippocampus       Date:  2011-03       Impact factor: 3.899

7.  Ultrastructural basis for interactions between central opioids and catecholamines. I. Rostral ventrolateral medulla.

Authors:  T A Milner; V M Pickel; D J Reis
Journal:  J Neurosci       Date:  1989-06       Impact factor: 6.167

8.  Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell.

Authors:  A L Svingos; E E Colago; V M Pickel
Journal:  J Neurosci       Date:  1999-03-01       Impact factor: 6.167

Review 9.  Cellular and molecular effects of steroid hormones on CNS excitability.

Authors:  Sheryl S Smith; Catherine S Woolley
Journal:  Cleve Clin J Med       Date:  2004-02       Impact factor: 2.321

10.  Seizures induce dramatic and distinctly different changes in enkephalin, dynorphin, and CCK immunoreactivities in mouse hippocampal mossy fibers.

Authors:  C Gall
Journal:  J Neurosci       Date:  1988-06       Impact factor: 6.167

View more
  12 in total

Review 1.  Sex differences in drug addiction and response to exercise intervention: From human to animal studies.

Authors:  Yuehui Zhou; Min Zhao; Chenglin Zhou; Rena Li
Journal:  Front Neuroendocrinol       Date:  2015-07-13       Impact factor: 8.606

2.  Sex Differences in Escalated Methamphetamine Self-Administration and Altered Gene Expression Associated With Incubation of Methamphetamine Seeking.

Authors:  Atul P Daiwile; Subramaniam Jayanthi; Bruce Ladenheim; Michael T McCoy; Christie Brannock; Jennifer Schroeder; Jean Lud Cadet
Journal:  Int J Neuropsychopharmacol       Date:  2019-11-01       Impact factor: 5.176

3.  Enkephalin levels and the number of neuropeptide Y-containing interneurons in the hippocampus are decreased in female cannabinoid-receptor 1 knock-out mice.

Authors:  Sophie A Rogers; Tracey A Van Kempen; Virginia M Pickel; Teresa A Milner
Journal:  Neurosci Lett       Date:  2016-03-21       Impact factor: 3.046

4.  Sex Differences in the Rat Hippocampal Opioid System After Oxycodone Conditioned Place Preference.

Authors:  James D Ryan; Yan Zhou; Natalina H Contoreggi; Farah K Bshesh; Jason D Gray; Joshua F Kogan; Konrad T Ben; Bruce S McEwen; Mary Jeanne Kreek; Teresa A Milner
Journal:  Neuroscience       Date:  2018-10-11       Impact factor: 3.590

5.  Characterization of neural estrogen signaling and neurotrophic changes in the accelerated ovarian failure mouse model of menopause.

Authors:  Tracey A Van Kempen; Jolanta Gorecka; Andreina D Gonzalez; Fumio Soeda; Teresa A Milner; Elizabeth M Waters
Journal:  Endocrinology       Date:  2014-06-13       Impact factor: 4.736

6.  Systematic review of sex-based differences in opioid-based effects.

Authors:  Andrew S Huhn; Meredith S Berry; Kelly E Dunn
Journal:  Int Rev Psychiatry       Date:  2018-12-06

Review 7.  Sex differences in opioid receptor mediated effects: Role of androgens.

Authors:  Jessica L Sharp; Tallia Pearson; Mark A Smith
Journal:  Neurosci Biobehav Rev       Date:  2022-01-04       Impact factor: 8.989

Review 8.  Sex differences in the rodent hippocampal opioid system following stress and oxycodone associated learning processes.

Authors:  Jasna Chalangal; Sanoara Mazid; Kyle Windisch; Teresa A Milner
Journal:  Pharmacol Biochem Behav       Date:  2021-11-06       Impact factor: 3.533

Review 9.  Is plasticity of GABAergic mechanisms relevant to epileptogenesis?

Authors:  Helen E Scharfman; Amy R Brooks-Kayal
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

10.  Hippocampal mossy fiber leu-enkephalin immunoreactivity in female rats is significantly altered following both acute and chronic stress.

Authors:  Joseph P Pierce; David T Kelter; Bruce S McEwen; Elizabeth M Waters; Teresa A Milner
Journal:  J Chem Neuroanat       Date:  2013-11-22       Impact factor: 3.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.